Suppr超能文献

慢性阻塞性肺疾病急性加重患者中鉴定出的各种病原体的临床意义:韩国的一项多中心研究

Clinical Significance of Various Pathogens Identified in Patients Experiencing Acute Exacerbations of COPD: A Multi-center Study in South Korea.

作者信息

Ji Hyun Woo, Yu Soojoung, Sim Yun Su, Seo Hyewon, Park Jeong-Woong, Min Kyung Hoon, Kim Deog Kyeom, Lee Hyun Woo, Rhee Chin Kook, Park Yong Bum, Shin Kyeong-Cheol, Yoo Kwang Ha, Jung Ji Ye

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

International Healthcare Center, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.

出版信息

Tuberc Respir Dis (Seoul). 2025 Apr;88(2):292-302. doi: 10.4046/trd.2024.0089. Epub 2024 Dec 30.

Abstract

BACKGROUND

Respiratory infections play a major role in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This study assessed the prevalence of bacterial and viral pathogens and their clinical impact on patients with AECOPD.

METHODS

This retrospective study included 1,186 patients diagnosed with AECOPD at 28 hospitals in South Korea between 2015 and 2018. We evaluated the identification rates of pathogens, basic patient characteristics, clinical features, and the factors associated with infections by potentially drug-resistant (PDR) pathogens using various microbiological tests.

RESULTS

Bacteria, viruses, and both were detected in 262 (22.1%), 265 (22.5%), and 129 (10.9%) of patients, respectively. The most common pathogens included Pseudomonas aeruginosa (17.8%), Mycoplasma pneumoniae (11.2%), Streptococcus pneumoniae (9.0%), influenza A virus (19.0%), rhinovirus (15.8%), and respiratory syncytial virus (6.4%). Notably, a history of pulmonary tuberculosis (odds ratio [OR], 1.66; p=0.046), bronchiectasis (OR, 1.99; p=0.032), and the use of a triple inhaler regimen within the past 6 months (OR, 2.04; p=0.005) were identified as significant factors associated with infection by PDR pathogens. Moreover, patients infected with PDR pathogens exhibited extended hospital stays (15.9 days vs. 12.4 days, p=0.018) and higher intensive care unit admission rates (15.9% vs. 9.5%, p=0.030).

CONCLUSION

This study demonstrates that a variety of pathogens are involved in episodes of AECOPD. Nevertheless, additional research is required to confirm their role in the onset and progression of AECOPD.

摘要

背景

呼吸道感染在慢性阻塞性肺疾病急性加重(AECOPD)中起主要作用。本研究评估了细菌和病毒病原体的患病率及其对AECOPD患者的临床影响。

方法

这项回顾性研究纳入了2015年至2018年期间韩国28家医院诊断为AECOPD的1186例患者。我们使用各种微生物学检测方法评估了病原体的识别率、患者基本特征、临床特征以及与潜在耐药(PDR)病原体感染相关的因素。

结果

分别在262例(22.1%)、265例(22.5%)和129例(10.9%)患者中检测到细菌、病毒以及两者。最常见的病原体包括铜绿假单胞菌(17.8%)、肺炎支原体(11.2%)、肺炎链球菌(9.0%)、甲型流感病毒(19.0%)、鼻病毒(15.8%)和呼吸道合胞病毒(6.4%)。值得注意的是,肺结核病史(比值比[OR],1.66;p = 0.046)、支气管扩张(OR,1.99;p = 0.032)以及过去6个月内使用三联吸入剂方案(OR,2.04;p = 0.005)被确定为与PDR病原体感染相关的重要因素。此外,感染PDR病原体的患者住院时间延长(15.9天对12.4天,p = 0.018),重症监护病房入住率更高(15.9%对9.5%,p = 0.030)。

结论

本研究表明多种病原体参与AECOPD发作。然而,需要进一步研究以证实它们在AECOPD发病和进展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/813f/12010712/affa34a4509f/trd-2024-0089f1.jpg

相似文献

1
Clinical Significance of Various Pathogens Identified in Patients Experiencing Acute Exacerbations of COPD: A Multi-center Study in South Korea.
Tuberc Respir Dis (Seoul). 2025 Apr;88(2):292-302. doi: 10.4046/trd.2024.0089. Epub 2024 Dec 30.
5
Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations.
J Clin Virol. 2009 Oct;46(2):129-33. doi: 10.1016/j.jcv.2009.07.010. Epub 2009 Aug 7.
6
The Relationship Between Comorbidities and Microbiologic Findings in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2022 Apr 20;17:855-867. doi: 10.2147/COPD.S360222. eCollection 2022.
9
Time-course of upper respiratory tract viral infection and COPD exacerbation.
Eur Respir J. 2019 Oct 10;54(4). doi: 10.1183/13993003.00407-2019. Print 2019 Oct.

本文引用的文献

1
Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific.
ERJ Open Res. 2022 Sep 26;8(3). doi: 10.1183/23120541.00057-2022. eCollection 2022 Jul.
2
Prevalence, Pattern, Risks Factors and Consequences of Antibiotic Resistance in COPD: A Systematic Review.
COPD. 2021 Dec;18(6):672-682. doi: 10.1080/15412555.2021.2000957. Epub 2022 Jan 11.
3
A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in Korea.
Tuberc Respir Dis (Seoul). 2022 Jan;85(1):37-46. doi: 10.4046/trd.2021.0080. Epub 2021 Oct 20.
4
Inhaled corticosteroid dose is associated with infection in severe COPD.
BMJ Open Respir Res. 2021 Oct;8(1). doi: 10.1136/bmjresp-2021-001067.
5
Use of inhaled corticosteroids and risk of acquiring in patients with chronic obstructive pulmonary disease.
Thorax. 2022 Jun;77(6):573-580. doi: 10.1136/thoraxjnl-2021-217160. Epub 2021 Aug 26.
8
Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary.
Tuberc Respir Dis (Seoul). 2018 Oct;81(4):261-273. doi: 10.4046/trd.2018.0029. Epub 2018 Jun 19.
10
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
Int J Chron Obstruct Pulmon Dis. 2017 Oct 19;12:3055-3064. doi: 10.2147/COPD.S143656. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验